Our mission is to help you obtain financial freedom. Checkout Our Youtube Channel Checkout Our Youtube Channel
Blog

NRDS Approaching the $17.66 Sell Target

Written By: ChartChamp

March 7, 2024

NRDS had a very impressive rally from the buy zone up to the red resistance line. There has been a lot of shady price action along the way, and I think NRDS is an extremely manipulated stock with insider trading. Some of the older members will remember the price suddenly dropping from $9 to $7 and rebounding to $10 within minutes. I think NRDS will continue to have tricky price action because of this insider trade activity. However, NRDS still managed to have a nice rally up to the long-term price target. NRDS is trying to flip $16.09 into resistance here, and the key target is the red trendline, which slopes downward so the price will decrease over time. The red trendline currently gives a price target around $17.66.

Previous Trade Setup from October 2023:

ChartChamp socials: https://linktr.ee/realchartchamp

0 Comments
Inline Feedbacks
View all comments

More ClearValue Insights

Default Thumbnail

SIRI Losing Support Despite 1:10 Reverse Stock Split

SIRI has announced a 1:10 reverse stock split, which is usually bearish for most stocks. SIRI is also losing support at a key support zone between $29.90 and $36.48. I think SIRI desperately needs to rebound around $24.50 to have any hope of climbing back above $29.90 support. If SIRI fails to remain above $24.50 […]

Read More
Default Thumbnail

MRNA Declines by 17% After Changes to Future Plans

Moderna announced plans to cut $1.1 billion in expenses by 2027 as it adapts to a post-COVID business environment. The company aims to win approval for 10 new products by 2027 but will also pause or scrap some projects to manage R&D spending. Moderna’s shares dropped by over 17% following the news, reflecting concerns about […]

Read More
Default Thumbnail

MPW Spikes Up After Severing Ties to Steward Health

Medical Properties Trust (MPW) announced a global settlement with Steward Health Care System and its creditors, which allows MPT to regain control over 15 hospitals and transition their operations to four new quality operators. The agreement ends MPT’s relationship with Steward and ensures that the hospitals remain operational under new management in states such as […]

Read More
Default Thumbnail

SIRI Losing Support Despite 1:10 Reverse Stock Split

SIRI has announced a 1:10 reverse stock split, which is usually bearish for most stocks. SIRI is also losing support at a key support zone between $29.90 and $36.48. I think SIRI desperately needs to rebound around $24.50 to have any hope of climbing back above $29.90 support. If SIRI fails to remain above $24.50 […]

Read More
Default Thumbnail

MRNA Declines by 17% After Changes to Future Plans

Moderna announced plans to cut $1.1 billion in expenses by 2027 as it adapts to a post-COVID business environment. The company aims to win approval for 10 new products by 2027 but will also pause or scrap some projects to manage R&D spending. Moderna’s shares dropped by over 17% following the news, reflecting concerns about […]

Read More
Default Thumbnail

MPW Spikes Up After Severing Ties to Steward Health

Medical Properties Trust (MPW) announced a global settlement with Steward Health Care System and its creditors, which allows MPT to regain control over 15 hospitals and transition their operations to four new quality operators. The agreement ends MPT’s relationship with Steward and ensures that the hospitals remain operational under new management in states such as […]

Read More